ENTO logo

Entero Therapeutics (ENTO) Non Current Assets

Annual Non Current Assets

$1.93 M
-$99.90 K-4.93%

31 December 2023

ENTO Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Non Current Assets

$1.98 M
+$77.90 K+4.10%

01 September 2024

ENTO Quarterly Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ENTO Non Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-+2.7%
3 y3 years-18.5%-16.4%
5 y5 years-64.9%-64.0%

ENTO Non Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-18.5%at low-97.6%+4.1%
5 y5 years-64.9%at low-97.6%+4.1%
alltimeall time-67.4%at low-97.6%+4.1%

Entero Therapeutics Non Current Assets History

DateAnnualQuarterly
Sept 2024
-
$1.98 M(+4.1%)
June 2024
-
$1.90 M(-97.7%)
Mar 2024
-
$83.64 M(+4240.6%)
Dec 2023
$4.96 M(+45.2%)
$1.93 M(-1.2%)
Sept 2023
-
$1.95 M(-1.2%)
June 2023
-
$1.97 M(-1.5%)
Mar 2023
-
$2.00 M(-1.1%)
Dec 2022
$3.41 M(-63.8%)
-
Dec 2022
-
$2.03 M(-3.3%)
Sept 2022
-
$2.10 M(-2.0%)
June 2022
-
$2.14 M(-6.0%)
Mar 2022
-
$2.28 M(-3.8%)
Dec 2021
$9.43 M(+19.8%)
$2.37 M(-51.9%)
Sept 2021
-
$4.92 M(-4.6%)
June 2021
-
$5.16 M(+7.3%)
Mar 2021
-
$4.81 M(-4.8%)
Dec 2020
$7.87 M
$5.05 M(-2.5%)
Sept 2020
-
$5.18 M(-1.5%)
June 2020
-
$5.26 M(-0.5%)
DateAnnualQuarterly
Mar 2020
-
$5.29 M(-3.8%)
Dec 2019
$3.41 M(-29.0%)
$5.49 M(-3.7%)
Sept 2019
-
$5.71 M(-4.6%)
June 2019
-
$5.98 M(-2.7%)
Mar 2019
-
$6.15 M(+130.5%)
Dec 2018
$4.80 M(+145.8%)
$2.67 M(-7.8%)
Sept 2018
-
$2.90 M(-6.8%)
June 2018
-
$3.11 M(-9.8%)
Mar 2018
-
$3.44 M(-2.4%)
Dec 2017
$1.95 M(-34.1%)
$3.53 M(-3.4%)
Sept 2017
-
$3.65 M(-2.2%)
June 2017
-
$3.73 M(+1.6%)
Mar 2017
-
$3.67 M(-3.1%)
Dec 2016
$2.96 M(+43.4%)
$3.79 M(-10.3%)
Sept 2016
-
$4.22 M(-2.3%)
June 2016
-
$4.32 M(-6.4%)
Mar 2016
-
$4.62 M(+0.1%)
Dec 2015
$2.07 M(+211.6%)
$4.62 M
Dec 2014
$663.50 K
-

FAQ

  • What is Entero Therapeutics annual long term assets?
  • What is the all time high annual non current assets for Entero Therapeutics?
  • What is Entero Therapeutics quarterly long term assets?
  • What is the all time high quarterly non current assets for Entero Therapeutics?
  • What is Entero Therapeutics quarterly non current assets year-on-year change?

What is Entero Therapeutics annual long term assets?

The current annual non current assets of ENTO is $1.93 M

What is the all time high annual non current assets for Entero Therapeutics?

Entero Therapeutics all-time high annual long term assets is $5.91 M

What is Entero Therapeutics quarterly long term assets?

The current quarterly non current assets of ENTO is $1.98 M

What is the all time high quarterly non current assets for Entero Therapeutics?

Entero Therapeutics all-time high quarterly long term assets is $83.64 M

What is Entero Therapeutics quarterly non current assets year-on-year change?

Over the past year, ENTO quarterly long term assets has changed by +$51.40 K (+2.67%)